NasdaqGM:LNTHMedical Equipment
Lantheus Holdings (LNTH) Agreed To Be Acquired, Is The Remaining Upside Already Priced In?
What the Curium acquisition means for Lantheus investors
Curium US LLC has agreed to acquire Lantheus Holdings (LNTH) in a transaction valued at up to US$8b, offering US$102.50 in cash per share at closing plus contingent value rights worth up to US$12.00 per share.
The contingent value rights are linked to commercial milestones for key Lantheus products through 2030. Until the deal closes, currently expected in the first half of 2027 subject to approvals, Lantheus will remain an independent,...